MwanzoAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$ 0.60
Baada ya Saa za Kazi:(4.02%)-0.024
$ 0.57
Imefungwa: 2 Apr, 19:58:02 GMT -4 · USD · NYSEAMERICAN · Kanusho
Bei iliyotangulia
$ 0.55
Bei za siku
$ 0.54 - $ 0.61
Bei za mwaka
$ 0.53 - $ 20.33
Thamani ya kampuni katika soko
4.85M USD
Wastani wa hisa zilizouzwa
6.69M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 21.00 | -53.33% |
Matumizi ya uendeshaji wa biashara | 2.93M | -50.23% |
Mapato halisi | -4.18M | 30.03% |
Kiwango cha faida halisi | elfu -19.88 | -49.93% |
Mapato kwa kila hisa | -0.44 | 95.60% |
EBITDA | -2.91M | 49.77% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 3.05M | -23.38% |
Jumla ya mali | 5.78M | -32.83% |
Jumla ya dhima | 15.56M | 56.75% |
Jumla ya hisa | -9.78M | — |
hisa zilizosalia | 8.15M | — |
Uwiano wa bei na thamani | -0.17 | — |
Faida inayotokana na mali | -130.90% | — |
Faida inayotokana mtaji | 171.11% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -4.18M | 30.03% |
Pesa kutokana na shughuli | -1.99M | 49.79% |
Pesa kutokana na uwekezaji | elfu -95.00 | -102.56% |
Pesa kutokana na ufadhili | 2.72M | 162.20% |
Mabadiliko halisi ya pesa taslimu | elfu 638.00 | -18.83% |
Mtiririko huru wa pesa | -1.43M | 74.40% |
Kuhusu
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Ilianzishwa
1966
Makao Makuu
Tovuti
Wafanyakazi
19
